PepGen Inc. (PEPG)
NASDAQ·Healthcare·Biotechnology
$1.59
-0.94%
Mkt Cap $106.44M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | — | — | — | -$0.40 | -$0.27 | +32.50% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.63 | -$0.52 | +17.46% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.85 | -$0.70 | +17.65% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.72 | -$0.92 | -27.78% | — | — |
| Q1 2025 Feb 24, 2025 | — | — | — | -$0.81 | -$0.68 | +16.05% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.87 | -$0.66 | +24.14% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.72 | -$0.87 | -20.83% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.74 | -$0.63 | +14.86% | — | — |
| Q1 2024 Mar 6, 2024 | — | $1.66M | — | -$1.01 | -$0.82 | +18.81% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.88 | -$0.98 | -11.36% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.81 | -$0.82 | -1.23% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.79 | -$0.69 | +12.66% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.87 | -$0.96 | -10.34% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$1.00 | -$0.79 | +21.00% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.76 | -$1.23 | -61.84% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.89 | -$0.89 | +0.31% | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$7.75 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$1.05 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.70 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.86 | — | — | — |